Last reviewed · How we verify
Intravenous Bolus Furosemide — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Intravenous Bolus Furosemide (Intravenous Bolus Furosemide) — Momentum Research, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intravenous Bolus Furosemide TARGET | Intravenous Bolus Furosemide | Momentum Research, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intravenous Bolus Furosemide CI watch — RSS
- Intravenous Bolus Furosemide CI watch — Atom
- Intravenous Bolus Furosemide CI watch — JSON
- Intravenous Bolus Furosemide alone — RSS
Cite this brief
Drug Landscape (2026). Intravenous Bolus Furosemide — Competitive Intelligence Brief. https://druglandscape.com/ci/intravenous-bolus-furosemide. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab